YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Bayer wins cancer firm Algeta with raised $2.9B bid

Posted online
Bayer has won backing from the board of Algeta, its partner for a new prostate cancer treatment, for an increased $2.9 billion offer to buy the Norwegian company.

Reuters reports the cash deal would give Bayer outright control over Xofigo, a drug the companies have developed jointly since 2009. It started selling in the U.S. this year.

Bayer initially offered $2.4 billion, but sweetened its offer.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences